Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes
about
Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions.Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.Functional avidity directs T-cell fate in autoreactive CD4+ T cells.Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypesLocalization of soluble major histocompatibility class II-peptide complexes on T cell surface.Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen.Distant interactions between dimorphisms in HLA-DR4 radically affect recognition of defined peptides by a specific T cell clone.Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens.
P2860
Q24815144-D7359F86-3C1C-4C1D-AD4C-C015A470EFFBQ34024236-8B916307-932C-4F9F-969B-226CA3419EBCQ35064131-134A203C-C4D8-439B-846D-967DAA9ACDABQ35848366-851755C4-92FF-4ACE-A936-741DF76E3261Q36222742-43B59060-CD07-4EC4-871F-3402D10F6C57Q36310443-312FA00A-0BA2-4244-AF81-7388140CA7ADQ37866131-74ABE106-73AE-48B3-A548-88FE7D449A56Q38477340-F2043A4B-E040-4A38-96C3-DA839C41F7A8Q39804601-FF9732BC-DAC6-4C3D-BAE5-FF3D6A7A3B54Q40861783-05722D68-4D70-4ABF-A42E-DF4A1227C7E2Q40862395-51BDD42D-09FE-4944-9D84-8F048862463AQ40953960-14714962-6304-40F6-8C76-4B9E1B564986Q41230546-4AA3287F-9376-42EF-A634-2964F84AF4C2Q42116021-E6044A9F-E3E9-4086-BB3C-8465FF8A6C28Q46257343-F53AB0AD-C059-4EE1-9A02-0619C4328D76
P2860
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Specific tolerance to an acety ...... lex class II-peptide complexes
@ast
Specific tolerance to an acety ...... lex class II-peptide complexes
@en
Specific tolerance to an acety ...... lex class II-peptide complexes
@nl
type
label
Specific tolerance to an acety ...... lex class II-peptide complexes
@ast
Specific tolerance to an acety ...... lex class II-peptide complexes
@en
Specific tolerance to an acety ...... lex class II-peptide complexes
@nl
prefLabel
Specific tolerance to an acety ...... lex class II-peptide complexes
@ast
Specific tolerance to an acety ...... lex class II-peptide complexes
@en
Specific tolerance to an acety ...... lex class II-peptide complexes
@nl
P2093
P2860
P356
P1476
Specific tolerance to an acety ...... lex class II-peptide complexes
@en
P2093
Ferguson DJ
Newsom-Davis J
Nicolle MW
P2860
P304
P356
10.1172/JCI117112
P407
P577
1994-04-01T00:00:00Z